Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $16.3B |
| Sales growthchange from the year before | +5.9% |
| Operating marginshare of sales left after running the business | 13.4% |
| Net marginshare of sales kept as profit | 8.3% |
| Return on invested capitalprofit made on each $100 put into the business | 7.8% |
| Return on equityprofit vs. shareholders' accounting value | 20.9% |
| Debt / equitydebt vs. shareholders' accounting value | 2.42 |
| Interest coverhow many times profit covers interest payments | 3.0x |
| Change in share countnegative = the company is buying back its shares | -5.4% |
5 insiders sold $29.2M on the open market.
| Staub W RichardSee Remarks | SoldAug 3 | 5,500 shat $232.68 · $1.3M |
| Patel BhavikSee Remarks | SoldJul 31 | 1,855 shat $235.27 · $436K |
| Bousbib AriSee Remarks · Director | SoldJul 29 | 106,279 shat $245.51 · $26.1M |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy